Related Experiment Video

Updated: May 29, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Continuous glucose monitoring and retinopathy of prematurity

Sophie Vanhaesebrouck1, Christine Vanhole, Claire Theyskens

  • 1Neonatal Intensive Care Unit, University Hospital Leuven, Leuven, Belgium. sophie.vanhaesebrouck@uzleuven.be

European Journal of Ophthalmology
|September 28, 2011
PubMed

Insights

Elevated glucose levels in the first week of life are linked to retinopathy of prematurity (ROP) in very low birthweight (VLBW) infants. Continuous glucose monitoring (CGMS) can help prevent ROP by monitoring these glucose levels.

Area of Science:

  • Neonatalogy
  • Ophthalmology
  • Endocrinology

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • The multifactorial etiology of ROP includes known risk factors, but the role of glucose metabolism is less understood.

Purpose of the Study:

  • To investigate the association between elevated glucose levels and ROP in very low birthweight (VLBW) infants.
  • To explore the potential of continuous glucose monitoring (CGMS) for ROP prevention strategies.

Main Methods:

  • Secondary analysis of the NIRTURE trial data, including 100 VLBW infants.
  • Utilized data from neonatal intensive care units, focusing on control subjects with conclusive ROP assessments.
  • Employed standard clinical care protocols and CGMS for glucose monitoring.

Main Results:

  • ROP development was associated with higher glycemia levels during the first week of life (p < 0.0001).
  • First-week glycemia demonstrated significant predictive power for ROP (ROC scores 0.67–0.80), with a median cutoff of 6.7 mmol/L.
  • The predictive value of glycemia was comparable to established classic risk factors for ROP.

Conclusions:

  • Moderately elevated glucose levels in the first week are a significant risk factor for ROP in VLBW infants.
  • Glucose monitoring via CGMS can aid in identifying infants at risk and inform preventive strategies for ROP.
  • Managing glycemia may be a crucial component in the multifactorial prevention of ROP.
Abstract

More Related Videos

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...